Viewing Study NCT00729950


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-29 @ 7:27 AM
Study NCT ID: NCT00729950
Status: COMPLETED
Last Update Posted: 2010-04-26
First Post: 2008-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module